Menlo Park, CA, United States of America

Clare Robert Gregory

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: American Home Products Corporation. Active years: 1996-1997.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 557(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Clare Robert Gregory: Innovator in Vascular Disease Treatment

Introduction

Clare Robert Gregory is a notable inventor based in Menlo Park, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of hyperproliferative vascular diseases. With a total of 4 patents to her name, her work has the potential to impact many lives.

Latest Patents

Among her latest patents is a method of treating hyperproliferative vascular disease. This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid. Another patent focuses on a similar approach, emphasizing the use of rapamycin for the same medical condition.

Career Highlights

Clare has worked with prominent companies in the pharmaceutical industry, including American Home Products Corporation and Wyeth. Her experience in these organizations has contributed to her expertise and innovative capabilities in developing treatments for vascular diseases.

Collaborations

Clare has collaborated with notable individuals in her field, including Randall E. Morris and Randall Ellis Morris. These partnerships have likely enhanced her research and development efforts.

Conclusion

Clare Robert Gregory's contributions to the treatment of hyperproliferative vascular diseases through her innovative patents highlight her role as a significant inventor in the medical field. Her work continues to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…